Rankings
▼
Calendar
PRGO FY 2017 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena
PRGO
Perrigo Company plc
$1B
FY 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$4.9B
-6.3% YoY
Gross Profit
$2.0B
40.0% margin
Operating Income
$598M
12.1% margin
Net Income
$120M
2.4% margin
EPS (Diluted)
$0.84
Cash Flow
Operating Cash Flow
$699M
Free Cash Flow
$610M
Stock-Based Comp.
$44M
Balance Sheet
Total Assets
$11.6B
Total Liabilities
$5.5B
Stockholders' Equity
$6.2B
Cash & Equivalents
$679M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4.9B
$5.3B
-6.3%
Gross Profit
$2.0B
$2.1B
-3.5%
Operating Income
$598M
-$2.0B
+129.9%
Net Income
$120M
-$4.0B
+103.0%
← Q4 2016
All Quarters
Q1 2017 →